These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15359824)

  • 1. [Treatment of fulminant hepatitis C or subacute hepatitis C].
    Inoue K; Yoshiba M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):371-5. PubMed ID: 15359824
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease.
    Inoue K; Yoshiba M
    Transplant Proc; 2005 Mar; 37(2):1233-4. PubMed ID: 15848679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of type C fulminant and subfulminant hepatitis--featuring antiviral and immunosuppressive treatment].
    Yoshiba M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):549-56. PubMed ID: 7563822
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C after liver transplantation.
    Sheiner PA
    Semin Liver Dis; 2000; 20(2):201-9. PubMed ID: 10946424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fulminant hepatitis C and subacute hepatitis C: pathological and clinical features].
    Yamada T
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):367-70. PubMed ID: 15359823
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT
    Clin Liver Dis; 2005 Aug; 9(3):473-86, viii. PubMed ID: 16023978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C after liver transplantation.
    Berenguer M
    Clin Liver Dis; 2005 Nov; 9(4):579-600, vi. PubMed ID: 16207565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.
    Wawrzynowicz-Syczewska M; Herman E; Jurczyk K; Karpińska E; Laurans Ł; Lubikowski J; Boroń-Kaczmarska A
    Transpl Int; 2007 Sep; 20(9):808-10. PubMed ID: 17578456
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C.
    Okano J; Horie Y; Kawasaki H; Kondo M
    Hepatogastroenterology; 1997; 44(14):525-8. PubMed ID: 9164531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of serum GBV-C RNA levels under administration of interferon and cyclosporine for patients with GBV infected hepatitis].
    Fujikawa H; Miyakawa H; Nagai K; Kako M
    Nihon Rinsho; 1997 Mar; 55(3):591-6. PubMed ID: 9086764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrahepatic manifestations of chronic viral hepatitis.
    Willson RA
    Am J Gastroenterol; 1997 Jan; 92(1):3-17. PubMed ID: 8995930
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive therapy allows recovery from liver failure in children with autoimmune hepatitis.
    Cuarterolo ML; Ciocca ME; López SI; de Dávila MT; Alvarez F
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):145-9. PubMed ID: 21029789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV-related fulminant hepatic failure: successful intensive medical therapy in a candidate for liver transplantation.
    Masuhara M; Yagawa T; Aoyagi M; Suzuki C; Sakaguchi E; Segawa M; Hironaka K; Kayano K; Tamura F; Seguchi M; Soejima Y; Murakami F; Sakaida I; Tateishi A; Fukumoto Y; Okita K
    J Gastroenterol; 2001 May; 36(5):350-3. PubMed ID: 11388400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in the treatment of fulminant hepatitis B].
    Yoshiba M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():280-3. PubMed ID: 15453330
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
    Cescon M; Grazi GL; Cucchetti A; Vetrone G; Ravaioli M; Ercolani G; Morelli MC; Piscaglia F; Tamè M; Pinna AD
    Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I; Ulloa E; Colina F; Abradelo M; Jiménez C; Gimeno A; Meneu JC; Lumbreras C; Solís-Herruzo JA; Moreno E
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation and hepatitis C.
    Willems M; Metselaar HJ; Tilanus HW; Schalm SW; de Man RA
    Transpl Int; 2002 Mar; 15(2-3):61-72. PubMed ID: 11935162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial.
    Calleri G; Colombatto P; Gozzelino M; Chieppa F; Romano P; Delmastro B; Macor A; Cariti G; Brunetto MR; Grillone W; Bonino F
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):181-4. PubMed ID: 9675655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulminant liver failure from acute HCV superinfection in a patient with HIV, HBV, and HDV coinfections.
    Lee K; Smith PT
    AIDS Read; 2000 Jul; 10(7):398, 401. PubMed ID: 10932838
    [No Abstract]   [Full Text] [Related]  

  • 20. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?].
    Pascal JP
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.